Cite

HARVARD Citation

    Hill, J. et al. (n.d.). Infectious Complications of CD19-Targeted Chimeric Antigen Receptor-Modified T Cell Immunotherapy. Open forum infectious diseases. pp. S698-S699. [Online]. 
  
Back to record